Fulminant hepatitis associated with hepatitis B virus e antigen–negative infection: Importance of host factors

The precore stop‐codon variant of hepatitis B virus (HBV) has been implicated in fulminant hepatitis. The precore/core regions of such variants from two sets of patients with interpartner transmission resulting in fulminant hepatitis in the contact, were sequenced to establish whether further sequence variations in the core region are specifically associated with the fulminant disease. In both sets of patients, there was sequence diversity of the precore/core region from the wild type, leading to numerous amino acid substitutions in the core region. Between the infecting source and the contact, there was only one amino acid change in one set of patients and none in the other. In addition, in the second set of patients, serum samples from four different time points were investigated. Sequence data showed no variation in each patient at the nucleotide level in the core region, even in the case of the source, who was followed for 3 years. In this same pair of subjects, the remainder of the genome was sequenced and was identical at the nucleotide level. Therefore, it appears that, at least in some cases of fulminant hepatitis caused by infection with the precore variant, the nucleotide sequence of the patient with fulminant hepatitis is identical to that observed in the asymptomatic source of infection. These data indicate that the severity and outcome of infection in such cases are unrelated to any additional variation in the entire HBV genome, and that the changed clinical picture is dependent on host factors, possibly the HLA environment. HLA typing of both the contact and source in the two sets of patients revealed that the contacts with fulminant hepatitis had one or more alleles at the HLA class II locus, previously shown to be associated with an acute hepatitis sufficient to clear the virus. (Hepatology 1995; 22:1628‐1634).

[1]  H C Thomas,et al.  Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. , 1995, The New England journal of medicine.

[2]  H. Thomas,et al.  Hepatitis B e antigen negative chronic active hepatitis: hepatitis B virus core mutations occur predominantly in known antigenic determinants , 1995, Journal of viral hepatitis.

[3]  K. Hasegawa,et al.  Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis , 1994, Journal of virology.

[4]  T. Shikata,et al.  Completely or nearly identical hepatitis B virus strains replicate between patients with acute or fulminant hepatitis B and their respective infectious sources , 1994, Journal of medical virology.

[5]  A. Horsch,et al.  Clinical significance of quantitative anti-HBc IgM assay in acute and chronic HBV infection. , 1993, Hepato-gastroenterology.

[6]  M. Bunce,et al.  Rapid HLA-DQB typing by eight polymerase chain reaction amplifications with sequence-specific primers (PCR-SSP). , 1993, Human immunology.

[7]  R. Purcell,et al.  The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. , 1993, Virology.

[8]  A. Vitiello,et al.  Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein , 1993, Journal of virology.

[9]  O. Yokosuka,et al.  Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. , 1993, The Journal of clinical investigation.

[10]  S. Mishiro,et al.  Fulminant hepatitis related to transmission of hepatitis B variants with precore mutations between spouses , 1992, Hepatology.

[11]  D. Kelly,et al.  Fulminant hepatitis B in infants born to anti-HBe hepatitis B carrier mothers. , 1992, BMJ.

[12]  F. Chisari,et al.  HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Chisari,et al.  Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen , 1991, The Journal of experimental medicine.

[14]  H. Thomas,et al.  Association of a precore genomic variant of hepatitis B virus with fulminant hepatitis , 1991, Hepatology.

[15]  O. Yokosuka,et al.  Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. , 1991, The New England journal of medicine.

[16]  J. Wands,et al.  A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. , 1991, The New England journal of medicine.

[17]  O. Yokosuka,et al.  Amino acid residues of core region of hepatitis B virus. Asymptomatic carriers versus patients with liver disease , 1991, Journal of gastroenterology and hepatology.

[18]  K. Takase,et al.  Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. , 1991, Gastroenterology.

[19]  F. Tsuda,et al.  Posttransfusion Fulminant Hepatitis B Associated with Precore‐Defective HBV Mutants , 1991, Vox sanguinis.

[20]  H. Thomas,et al.  MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION , 1989, The Lancet.

[21]  M. Alter,et al.  A common-source outbreak of fulminant hepatitis B in a hospital. , 1989, Annals of internal medicine.

[22]  A. Alberti,et al.  Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection. , 1987, Clinical and experimental immunology.

[23]  Roger Williams,et al.  FULMINANT HEPATITIS B IN SUCCESSIVE FEMALE SEXUAL PARTNERS OF TWO ANTI-HBe-POSITIVE MALES , 1986, The Lancet.

[24]  H. Thomas,et al.  HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection , 1986, Hepatology.

[25]  D. Vergani,et al.  Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. , 1982, Journal of immunology.

[26]  F. Galibert,et al.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli , 1979, Nature.

[27]  J. Squire,et al.  SECOND THOUGHTS ON THE WILLINK REPORT , 1960 .

[28]  O. Yokosuka,et al.  Precore mutations and core clustering mutations in chronic hepatitis B virus infection. , 1993, Gastroenterology.

[29]  J. Sung,et al.  Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. , 1992, The Journal of clinical investigation.

[30]  Brunetto Identification of HBV variants which cannot produce pre-core derived HBeAg and may be responsible for severe hepatitis , 1989 .

[31]  B. Schwartz Letter: Ondine's curse. , 1976, Lancet.